Kavar Capital Partners Group’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-4,500
| Closed | -$1K | – | 503 |
|
|
2019
Q2 | $1K | Buy |
+4,500
| New | +$1K | ﹤0.01% | 500 |
|
|
2018
Q3 | – | Sell |
-1,500
| Closed | -$2K | – | 437 |
|
|
2018
Q2 | $2K | Hold |
1,500
| – | – | ﹤0.01% | 420 |
|
|
2018
Q1 | $3K | Buy |
+1,500
| New | +$3K | ﹤0.01% | 398 |
|
|
2016
Q1 | – | Sell |
-1,500
| Closed | -$9K | – | 456 |
|
|
2015
Q4 | $9K | Hold |
1,500
| – | – | 0.01% | 276 |
|
|
2015
Q3 | $11K | Hold |
1,500
| – | – | 0.01% | 278 |
|
|
2015
Q2 | $9K | Buy |
+1,500
| New | +$9K | 0.01% | 307 |
|
|
2014
Q2 | – | Sell |
-2,000
| Closed | -$13K | – | 486 |
|
|
2014
Q1 | $13K | Hold |
2,000
| – | – | 0.01% | 297 |
|
|
2013
Q4 | $11K | Buy |
+2,000
| New | +$11K | 0.01% | 293 |
|